Dimensional Fund Advisors’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History

Dimensional Fund Advisors’s Portfolio OSIR Stock Details OSIR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-300	Closed	-$5K	–	3540
2014 Q4	$5K	Hold	300	–	–	﹤0.01%	3486
2014 Q3	$4K	Sell	300 -3,155	-91%	-$45K	﹤0.01%	3524
2014 Q2	$54K	Sell	3,455 -61,527	-95%	-$905K	﹤0.01%	3432
2014 Q1	$853K	Sell	64,982 -25,638	-28%	-$401K	﹤0.01%	3070
2013 Q4	$1.46M	Sell	90,620 -500	-0.5%	-$7.97K	﹤0.01%	2935
2013 Q3	$1.52M	Sell	91,120 -7,644	-8%	-$113K	﹤0.01%	2939
2013 Q2	$995K	Buy	+98,764	New	+$1.04M	﹤0.01%	3025

Other funds holding OSIR

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

VCM

Venator Capital Management Toronto, Ontario, Canada $48.7M AUM 87.97% 1-Year Est. Return

OAM

Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return

Dimensional Fund Advisors's OSIR Position: Q1 2015 in Review

Dimensional Fund Advisors sold out of Osiris Therapeutics, Inc. Common Stock (OSIR) in Q1 2015, closing a stake of 300 shares — an estimated $5K sold.

Dimensional Fund Advisors first reported a position in OSIR in Q2 2013 and held it in 7 quarters. The position peaked at $1.52M in Q3 2013. 83 funds tracked by Wall St. Rank hold OSIR as of Q1 2015.

Dimensional Fund Advisors reported no remaining Osiris Therapeutics, Inc. Common Stock position as of Q1 2015 after selling out during the quarter.
Dimensional Fund Advisors sold 300 Osiris Therapeutics, Inc. Common Stock shares in Q1 2015, an estimated $5K.
Dimensional Fund Advisors first reported a position in Osiris Therapeutics, Inc. Common Stock in Q2 2013 and held it in 7 quarters.
Dimensional Fund Advisors's Osiris Therapeutics, Inc. Common Stock position peaked at $1.52M in Q3 2013.
83 funds tracked by Wall St. Rank held Osiris Therapeutics, Inc. Common Stock as of Q1 2015.

Based on Dimensional Fund Advisors's 13F filing for Q1 2015, filed 14 May 2015.